CMI/Compas promoted two leaders into EVP, Managing Director roles: Elizabeth Barron and Justin Freid.
McCann Health announced the appointment of Daniel Carucci, MD, MSc, PhD, to the new position of Global Medical Director.
Eisai’s Phase III Trial Results of Anticancer Agent Lenvatinib in Hepatocellular Carcinoma Published in The Lancet
Eisai Co. Ltd. announced that the results of a Phase III study of its in-house discovered and developed anticancer agent lenvatinib mesylate in patients with hepatocellular carcinoma were published in the online version of The Lancet.
Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Lisa van Capelle as Chief Human Resources Officer (CHRO).
Digital marketing agency closerlook inc. appointed Steve Tulk to the role of Chief Technology Officer.
Ashfield, part of leading international healthcare services provider UDG Healthcare, announced the appointment of Doug Burcin as president of Ashfield Healthcare Communications.
EGP-437 demonstrated better clinical performance than vehicle control, but did not meet its co-primary endpoints.
The Vilcek Foundation announced the winners of the 2018 Vilcek Prizes in Biomedical Science. Awarded annually, the prizes call attention to the breadth of immigrant contributions to science in the United States. In parallel, the Vilcek Foundation also awards prizes for immigrant accomplishments in the arts.
Publicis Health, a division of Publicis Groupe, announced the elevation of Alexandra von Plato to the role of Chief Executive Officer for Publicis Health effective immediately.
W2O announced the appointment of Rita Glaze as Practice Leader of Value, Pricing and Market Access to strengthen its healthcare commercialization offering.
Reaction Biology Corporation, a leading contract research organization providing early-stage drug discovery services, announced that it has launched a new division to provide ion-channel discovery services.
June Laffey was appointed to the new position of Executive Vice President, Chief Creative Officer, McCann Health New York.
McCann Health announced the appointment of Linda Szyper to the new position of Global Chief Operating Officer.
PALIO will fuse with GSW to deliver customers the best of both agencies’ integrated advertising and marketing solutions.
In this newly created role, Jennifer Gottlieb is responsible for three operating companies – W2O wcg, W2O twist and W2O pure.
The U.S. FDA granted Priority Review to daratumumab as a combination treatment for patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.
The European Commission granted Marketing Authorization for Shire’s ADYNOVI [Antihemophilic Factor (Recombinant), PEGylated], for on-demand and prophylactic use in patients 12 years and older living with hemophilia A.
Mr. du Toit is responsible for leading Publicis Health’s global business development strategy.
Outcome Health, which provides health education at the moment of care to improve patient outcomes, announced that Vince Panozzo was promoted to Executive Vice President of Sales.